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Abstract
Background: The glutamate synthase operon (gltBDF) contributes to one of the two main pathways of ammonia
assimilation in Escherichia coli. Of the seven most-global regulators, together affecting expression of about half of
all E. coli genes, two were previously shown to exert direct, positive control on gltBDF transcription: Lrp and IHF.
The involvement of Lrp is unusual in two respects: first, it is insensitive to the usual coregulator leucine, and
second, Lrp binds more than 150 bp upstream of the transcription starting point. There was indirect evidence for
involvement of a third global regulator, Crp. Given the physiological importance of gltBDF, and the potential
opportunity to learn about integration of global regulatory signals, a combination of in vivo and in vitro approaches
was used to investigate the involvement of additional regulatory proteins, and to determine their relative binding
positions and potential interactions with one another and with RNA polymerase (RNAP).
Results: Crp and a more local regulator, ArgR, directly control gltBDF transcription, both acting negatively. Crp-
cAMP binds a sequence centered at -65.5 relative to the transcript start. Mutation of conserved nucleotides in
the Crp binding site abolishes the Crp-dependent repression. ArgR also binds to the gltBDF promoter region,
upstream of the Lrp binding sites, and decreases transcription. RNAP only yields a defined DNAse I footprint
under two tested conditions: in the presence of both Lrp and IHF, or in the presence of Crp-cAMP. The DNAse
I footprint of RNAP in the presence of Lrp and IHF is altered by ArgR.
Conclusion: The involvement of nearly half of E. coli's most-global regulatory proteins in the control of gltBDF
transcription is striking, but seems consistent with the central metabolic role of this operon. Determining the
mechanisms of activation and repression for gltBDF was beyond the scope of this study. However the results are
consistent with a model in which IHF bends the DNA to allow stabilizing contacts between Lrp and RNAP, ArgR
interferes with such contacts, and Crp introduces an interfering bend in the DNA and/or stabilizes RNAP in a
poised but inactive state.
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A small number of global regulatory proteins appear to
play a central role in integrating the regulatory architec-
ture of Escherichia coli, so as to promote coherent tran-
scriptional responses to environmental changes. Just
seven proteins (ArcA, Crp, FIS, Fnr, IHF, Lrp, and NarL)
directly control expression of about half of all genes in E.
coli [1]. We report here direct evidence that three of these
seven proteins, plus a more specific regulator, cooperate
to control an operon critical to nitrogen metabolism.
There are two main pathways for assimilating ammonia
into glutamate in Escherichia coli [2] (see Fig. 1). In the
presence of high ammonia concentrations and limited
carbon/energy, glutamate dehydrogenase (GdhA) pro-
duces glutamate from ammonia, α-ketoglutarate, and
NADPH [equation 1, and left side of Fig. 1].
NH4+ + α-Ketoglutarate + NADPH → Glutamate + NADP+
 [1]
At low ammonia concentrations, a two-enzyme cycle is
used instead. First, glutamine synthetase (GlnA) produces
glutamine from ammonia, glutamate and ATP [equation
2]. Then glutamate synthase (GltBD) produces two mole-
cules of glutamate from glutamine, α-ketoglutarate, and
NADPH [equation 3], with one of the glutamate mole-
cules going back into the cycle and the other representing
net ammonia incorporation [equation 4, and right side of
Fig. 1]. The only difference between equations [1] and [4]
is the involvement of ATP.
NH4+ + Glutamate + ATP → Glutamine + ADP + Pi  [2]
Glutamine + α-Ketoglutarate + NADPH → 2 Glutamate +
NADP+  [3]
NH4+ + α-Ketoglutarate + NADPH + ATP → Glutamate +
NADP+ + ADP + Pi [4]
In the presence of high ammonia levels, GltBD activity
would waste ATP as a result of unnecessary glutamine
turnover. The pathway represented by equation 4 is esti-
mated to account for a remarkable 15% of total ATP turn-
over during growth in glucose minimal medium [2], so
the ATP wastage would be substantial. However, insuffi-
cient GltBD activity in the face of dropping ammonia lev-
els would lead to cessation of growth [3,4] and a
competitive disadvantage. Clearly the level of GltBD must
be very carefully controlled so as to anticipate the proba-
ble near-term needs of the cell.
Our interest in gltBDF, the operon that includes structural
genes for GltBD, stems from its membership in the regu-
lon controlled by Lrp (leucine-responsive regulatory pro-
tein) [5]. There is no obvious single role for Lrp, but three
broad themes stand out. First, Lrp appears to sense the
shift between two major E. coli environments, "the gut
and the gutter" [6], activating many amino acid biosyn-
thetic operons (such as gltBDF) and repressing many cat-
abolic ones. Second, and partially overlapping the first,
Lrp plays an important role in regulating nitrogen metab-
olism [2,5,7]. Third, Lrp appears to play an important role
in preparing the cell for stationary phase [6,8-13].
In the gltBDF operon, IHF binds the region from -75 to -
113, while the three Lrp binding sites are centered at
nucleotides -152, -215 and -246 relative to the transcrip-
tion start site [5,14] (Fig. 2A). This arrangement leaves
space for other proteins to bind, and it seemed likely that
additional regulators would be involved in controlling a
pathway that can account for 15% of the cell's ATP flux.
There is some evidence for effects (direct or indirect) of
other regulators on gltBDF expression, including Crp [15],
Fnr [16], Nac [17], and GadE [18] (see information on the
gltBDF operon at EcoCyc.org [19]). We report here that
gltBDF is directly and negatively controlled by Crp and
ArgR, in addition to the direct positive control by Lrp and
IHF. We also show that RNAP binds stably to the gltBDF
promoter in the presence of Lrp and IHF, or in the pres-
ence of Crp-cAMP.
Results
Effects of Lrp and IHF on RNAP binding to the gltBDF 
promoter region
We have previously shown that Lrp and IHF bind simulta-
neously to gltBDF promoter (PgltB) DNA, yielding a band
with intermediate gel shift mobility between the IHF-
DNA and Lrp-DNA complexes (Fig. 3C in [14]). Fig. 3A
shows that the Lrp-binding region yields a subtly altered
Lrp-dependent DNAse I footprint in the presence of IHF,
though the IHF footprint is not obviously changed by the
presence of Lrp.
RNA polymerase holoenzyme (RNAP) binds to PgltB in
the absence of other proteins, as revealed by electro-
phoretic mobility shift of a DNA segment from -406 to
+131 (relative to the transcription start; not shown). How-
ever DNAse I footprinting analysis of this binary complex
revealed no obvious regions of protection (Fig. 3B, com-
pare lanes 5 and 6). Since the absence of either Lrp or IHF
leads to a >30-fold reduction in gltBDF transcription
[5,14], we investigated whether these two proteins influ-
ence RNAP binding to PgltB. Mobility shift experiments
were not informative as, under our conditions, the large
shift due to RNAP alone was indistinguishable from shifts
due to RNAP together with Lrp and/or IHF. However
DNAse I protection analysis revealed that the combina-
tion of Lrp, IHF and RNAP results in a footprint in the pro-
moter region, with strongly enhanced cleavage at the -19Page 2 of 17
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Biosynthesis and metabolic uses of L-glutamic acidF gure 1
Biosynthesis and metabolic uses of L-glutamic acid. The two alternative pathways from α-ketoglutarate (αKG) to gluta-
mate (Glu) are shown by the thick arrows, as described by equations 1–4 in the Introduction. The gray arrow (left) represents 
equation 1, while the black arrow (right) represents the net sum of equations 2 and 3 (i.e., equation 4). Glu is one of the small 
minority of amino acids for which the great bulk of the molecules are used for purposes other than direct incorporation into 
proteins [2]. A number of transaminases use the α-amino group of Glu. Other uses of Glu were identified from the BioCyc 
website [63].
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remainder of the region between the -10 and -35 hexam-
ers (Fig. 3B, compare lane 7 to lanes 5 and 6). This protec-
tion extended ~30 bp upstream of the -35 hexamer,
merging with the footprint of IHF, and some protection
was visible even farther upstream between the IHF and
Lrp binding sites. A combination of just Lrp and IHF does
not result in any additional footprint aside from those of
the individual proteins [14], and in particular the
extended protection upstream of the -35 hexamer is not
seen in the absence of RNAP (Fig. 3A).
Crp-cAMP regulation of gltBDF transcription
We searched for proteins from an E. coli whole-cell extract
that bound to immobilized, biotinylated PgltB DNA,
using Ciphergen ProteinChips™ and mass spectrometry.
This method had previously implicated IHF as a factor
involved in gltBDF regulation, as we subsequently con-
firmed [14], but additional mass peaks representing other
DNA binding proteins had not yet been investigated. The
analysis suggested ArgR (regulator for the arginine regu-
lon) and Crp (catabolite repressor protein) as potential
additional regulators of gltBDF (Fig. 4). Several decades
ago Prusiner et al. reported negative regulation of gluta-
mate synthase expression by Crp [15]. Specifically, gluta-
mate synthase activity is doubled in a mutant lacking
adenylate cyclase (cya), and reduced 1.5-fold by addition
of exogenous cAMP or growth with glycerol as the carbon
source (which increases cAMP levels) [15]. However, it
was not determined whether these results involved direct
interactions between Crp and PgltB.
Our inspection of the gltBDF DNA sequence revealed a
potential Crp-binding site between -76 and -55 (Fig. 5A,
top two lines). We have not attempted to measure tran-
scription of a gltB-lacZ fusion in isogenic crp and crp+
strains, to complement the earlier data of Prusiner et al.
[15]. This is because the crp mutant grows much more
slowly than its isogenic partner [20], and comparisons
would be complicated by the different growth rates [21].
However we have taken three complementary approaches
to demonstrate a direct effect of Crp-cAMP on glt tran-
scription.
First, we carried out mobility shift assays using purified
Crp and a gltBDF DNA fragment containing the region
from -406 to +246. Crp bound the glt DNA with an appar-
ent Kd of 35 nM in the presence of 20 μM cAMP (Fig. 5B).
Replacing the region between -121 and -48 with heterolo-
gous DNA [14] resulted in loss of detectable binding (Fig.
5C). When cAMP was not added to the gel, but was
present in the binding reaction, binding was still observed
but the shifted bands were smeared, suggesting that the
complexes were unstable under this condition (not
shown).
gltBDF promoter regionFigure 2
gltBDF promoter region. A. Sequence of region upstream 
of gltB. Nucleotides shown as shaded capitals represent pro-
moter elements or binding sites for the indicated regulatory 
proteins, as identified in this work and earlier studies (see 
references in text). The borders shown for binding sites are 
based on comparison to consensus sequences, and are con-
sistent with DNAse I footprints reported in this study. The 
binding site for Fnr is shown as a dashed box because it has 
not been experimentally confirmed (see information on glt-
BDF at BioCyc.org). The color-shaded background indicates 
three broad regions of the promoter (initiation region, blue; 
Lrp-binding region, green; ArgR-binding region, yellow). B. A 
model for gltBDF transcriptional regulation. Lrp and IHF bind 
and, according to the model, bend gltBDF promoter DNA 
such that an upstream regulatory sequence or Lrp surface 
required for stable binding of RNAP is brought in contact 
with RNAP that is loosely associated with the promoter 
region. This positive interaction (and not Lrp binding) is par-
tially abolished by ArgR-Arg bound to glt DNA. In the pres-
ence of Crp-cAMP, RNAP association with the promoter is 
stabilized but in a nonproductive manner, leading to tran-
scriptional repression. Background shading matches that in 
part A.
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DNAse I protection of the gltBDF promoter region by Lrp, IHF, and RNA polymeraseFigur 3
DNAse I protection of the gltBDF promoter region by Lrp, IHF, and RNA polymerase. A. DNase I protection 
assay of gltBDF promoter region in the presence of both Lrp and IHF. A fragment of gltB DNA from -325 to +8 was used in the 
reaction. The first 4 lanes represent a sequencing ladder of the region. In all cases where it was added, Lrp was used at 2 nM. 
The amounts of IHF are shown in nM. B. A fragment of gltB DNA from -571 to +51, labeled at the +51 end of the template 
strand using 32P, was used. When present, the concentration of RNAP was 30 nM, Lrp 100 nM and IHF 100 nM. The first 4 
lanes represent a sequencing ladder of the template strand of the region.
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BMC Microbiology 2007, 7:2 http://www.biomedcentral.com/1471-2180/7/2Second, we carried out DNAse I footprint analyses, using
purified Crp, cAMP, and PgltB DNA. A defined region of
partial protection was seen between -71 and -52 on the
non-template strand (Fig. 5E), and -72 to -57 on the tem-
plate strand (not shown). Thus Crp-cAMP interacts
directly with PgltB. The Crp binding is centered at -65.5, in
the predicted binding sequence (-76 to -55), and between
the -35 hexamer and the IHF binding site (Fig. 2A).
Third, we determined the effects of the membrane-perme-
able derivative dibutyryl-cAMP on expression of gltB-lacZ
with and without alteration of the Crp binding sequence.
The alterations are shown in Fig. 5A (bottom line), and
replace all of the most highly-conserved nucleotides of
known Crp-binding sequences (shaded) that were not
already different in the native gltBDF promoter. Concen-
trations of dibutyryl-cAMP as high as 50 μM had no effect
on the growth rate of the cultures (not shown), and we
used 10 μM in the experiments described here. As a con-
trol, parental strain W3110 (with an intact lac operon)
was grown in a defined glucose rich medium plus the
inducer IPTG. As shown in Fig. 6A, dibutyryl-cAMP had
the expected effect of increasing lacZ expression in the
parental strain, due to relief of catabolite repression [22].
In contrast, Fig. 6B shows that dibutyryl-cAMP reduced
expression of lacZ fused to WT PgltB, while Fig. 6C shows
that dibutyryl-cAMP had no effect on lacZ fused to PgltB
having the altered Crp binding sequence. Similar results
were obtained in glucose minimal medium (not shown).
As Crp most often acts as a transcription activator, we
explored some possible explanations for its repressive
effect on PgltB. One possibility, given the proximity of the
Crp and IHF binding sites (Fig. 2A), and the requirement
of IHF for activation by Lrp [14], is that Crp interferes with
IHF binding. However mobility shift analysis indicates
that Crp and IHF bind independently of one another (Fig.
5D), though the ternary and binary complexes could not
be resolved from one another well enough to completely
rule out limited negative (or positive) cooperativity in
their binding.
A second possibility, which we did not test, is that the Crp-
induced bend in the DNA [23] opposes that generated by
IHF, preventing proper activation. A third possibility is
that Crp interferes with RNAP binding. As noted above,
RNAP alone fails to yield a clear protection pattern on
PgltB DNA. Adding Crp-cAMP, far from interfering with
RNAP binding, resulted in the appearance of a well-
defined pattern of RNAP-dependent protection (Fig. 7).
This pattern is, however, distinct from that seen when the
coactivators Lrp and IHF are added in place of Crp (Fig.
3B). One particularly striking difference, as an example, is
the DNase cleavage at position -19, that shows hypersen-
sitivity in the presence of Lrp + IHF but not in the presence
of Crp (compare lane 7 of Fig. 3B to lane 7 of Fig. 7).
ArgR-Arg regulation of gltBDF transcription
The Ciphergen ProteinChip™ analysis referred to above
yielded another E. coli polypeptide bound to PgltB DNA,
having a molecular mass close to that of the regulatory
protein ArgR (Fig. 4A). The involvement of ArgR in gltBDF
regulation is reinforced by the following three observa-
tions. First, adding 7.5 mM L-arginine to MOPS-glucose
medium nearly halved LacZ activity, in the gltB-lacZ
fusion strain LP1000 (and its isogenic rph+ strain LP2020;
see below) (Table 1). Second, deleting argR from strains
LP1000 (LP1050) or LP2020 (LP2023) doubled LacZ
activity. Third, adding arginine to the growth medium did
not affect LacZ levels in the ΔargR strain LP1050.
We have evidence that ArgR mediates its regulatory effect
on the gltBDF promoter via direct interaction. There are
two good matches to the consensus ArgR binding site
sequence [24,25] upstream of the promoter-distal Lrp
binding site (Figs. 2A and 8A). When gltBDF DNA con-
taining the putative ArgR sites upstream of -270 was
deleted, arginine had no effect on gltB-lacZ expression
(strain LP1270, Table 1). We extended this observation by
using purified ArgR in mobility shift and DNAse I foot-
print analyses. ArgR bound to gltB DNA (-406 to +246)
with a Kdapp of 1.8 ± 0.7 nM (Fig. 8B), and to a 3'-short-
ened fragment (-406 to -128) with essentially the same
affinity (Kdapp of 1.7 ± 0.06 nM; not shown). These data
were fitted using the Hill equation as previously described
Masses of polypeptides associated with gltB DNA in vitroFigure 4
Masses of polypeptides associated with gltB DNA in 
vitro. Surface-enhanced laser desorption and ionization 
(SELDI; Ciphergen Biosystems) was used to identify proteins 
from whole-cell E. coli extracts binding to biotin-labeled gltB 
DNA (from -406 to +246). The DNA was attached to 
streptavidin-coated chips, incubated with the extracts, and 
washed prior to mass analysis. Parts A and B show different 
mass ranges. The vertical arrows indicate the theoretical 
positions of the indicated polypeptides; in each case the mass 
shown assumes removal of the N-terminal methionine.
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Interactions between Crp and the gltBDF promoter regionFigure 5
Interactions between Crp and the gltBDF promoter region. A. The glt Crp-binding sequence (top) compared to the 
consensus Crp binding sequence (middle). The most-conserved elements of the Crp sequence are shaded, and matches to the 
consensus are underlined. The bottom sequence shows the mutations (lowercase) that were introduced for the experiment 
shown in Fig. 6. B. Gel mobility shift analysis of Crp binding to glt DNA region -406 to +246. The running buffer and gel con-
tained 20 μM cAMP. C. Gel mobility shift analysis as in (B), except that two DNAs are used. One is WT, and the other has the 
region from -128 to -48 replaced by an equal length of exogenous DNA (amplified from the coding region of the cat gene). D. 
Gel mobility shift assay showing simultaneous binding of Crp and IHF to gltBDF DNA. A fragment of gltB DNA from -203 to +8 
was used in the assay. E. DNAse I protection of glt DNA by Crp binding. A gltB DNA fragment from -203 to +161 labeled at 
the -203 end of the partner strand was used for the assay. The first 4 lanes represent the sequencing ladder of the partner 
strand. Crp concentrations of 0, 12.5, 25, 50, 100 and 200 nM were used in the assay.
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Hill coefficient of 2.0, indicating that multiple ArgR mol-
ecules are binding cooperatively.
The sequence to which ArgR binds was determined by
DNase I protection using gltB DNA from -462 to +161.
ArgR protected a region upstream of the distal Lrp binding
site (Figs. 2A and 8C), extending from -361 to -318 on the
non-template strand. This encompasses the two ArgR con-
sensus-matching sites, and is consistent with the Hill coef-
ficient of 2.0. Similar results were obtained for the
template strand (not shown; a longer fragment, extending
from -575 to +131, gave lower resolution due to the posi-
tion of the footprint on the fragment).
We considered two possibilities for the basis of gltBDF
repression by ArgR. First, given the proximity of the ArgR
and Lrp binding sites (Fig. 2A), we tested whether ArgR
interfered with Lrp binding. Mobility shift assays with
ArgR and Lrp were inconclusive in this respect, because
adding the corepressor arginine to the gel prevented the
Lrp-DNA complex from migrating far into the gel (not
shown). However DNAse I footprint analyses suggest that
Lrp and ArgR bind independently of one another (Fig.
9A).
A second possible basis for repression of gltBDF by ArgR
involves interference with the proposed Lrp-RNAP inter-
action. ArgR does in fact alter the protection pattern gen-
erated by the combination of Lrp, IHF, and RNAP (Fig. 9B,
asterisks). In the absence of ArgR there is a limited region
of RNAP-dependent hypersensitivity that overlaps the
ArgR binding site; addition of ArgR and arginine alters this
hypersensitivity pattern.
Effects of rph on gltBDF expression
We considered the possibility that our measurements of
gltBDF expression were being affected by a defect in the E.
coli W3110 background. This commonly-used K-12 strain
carries a frameshift mutation in rph, the structural gene for
RNAsePH, that results in decreased pyrE (orotate phos-
phoribosyltransferase) expression and in turn leads to
pyrimidine limitation during growth in minimal media
[29]. Pyrimidine biosynthesis is regulated by feedback
inhibition, so it seemed plausible that W3110 would
sense increased demand for glutamate (to provide needed
glutamine precursors), and would thus have elevated glt-
BDF expression. Consistent with this possibility, adding
20 μg/ml of the pyrimidine uracil to strain LP1000 in
minimal medium resulted in a 1.5 fold reduction of PgltB-
lacZ activity (strain LP1000 is a W3110 derivative carrying
Effects of dibutyryl-cAMP on expression from PgltBDF and a mutant form with altered Crp binding sitesFigure 6
Effects of dibutyryl-cAMP on expression from PgltBDF and a mutant form with altered Crp binding sites. Cells 
were grown in a MOPS-based defined glucose rich medium with (closed symbols) or without (open symbols) 10 μM dibutyryl-
cAMP. All strains were Crp+. A. Expression of the native lac operon (strain W3110). B. Expression of a PgltBDF-lacZ fusion 
(strain PM2003). C. Expression of a fusion of lacZ to the mutant version of PgltBDF shown in the bottom line of Fig. 5A (strain 
PM2004).Page 8 of 17
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BMC Microbiology 2007, 7:2 http://www.biomedcentral.com/1471-2180/7/2a gltB-lacZ fusion in a Δlac background). We replaced the
W3110 rph allele with the wild-type gene (see Methods),
and the new strain was designated LP2002. Correcting the
rph mutation roughly halved transcription from PgltB in
strain LP2020 (strain LP2002 bearing Δlac and a gltB-lacZ
fusion, see Table 2), in agreement with the uracil addition
results. Strain LP2002 may be generally useful for studies
of E. coli physiology.
Discussion
Role of IHF in mediating activation of gltBD by Lrp
IHF, a DNA-bending protein [30], is required for activa-
tion of gltBDF transcription by Lrp [14]. IHF subtly affects
the Lrp-dependent DNAse I footprint (Fig. 3A), suggesting
that IHF alters the Lrp-DNA complex (or alters DNAse I
access to that complex). In addition, IHF bending could
bring the Lrp-DNA complex into activating contact with
RNAP at PgltB (Fig. 2B). IHF plays an architectural role at
several activated promoters, such as PilvP [31]. We have
not directly demonstrated looping, but two results sup-
port this view. First, no defined footprint for RNAP was
seen at PgltB with either IHF or Lrp alone, only with both
together (Fig. 3B and our unpublished results). Second,
an earlier study demonstrated that a 5 bp (half helical
turn) insertion between the proximal Lrp binding site and
the promoter reduced gltB-lacZ expression 3-7-fold, while
a 10 bp (full helical turn) insertion at the same location
did not reduce fusion expression (Fig. 5B of Wiese et al.
[26]). Bending or looping models do not rule out the pos-
sibility of direct RNAP-IHF contacts occurring as well [32].
Does Crp pre-position RNAP in response to energy 
metabolism?
The flux through the GlnA/GltBD pathway can be quite
high in minimal media. ATP is required for the GlnA/
GltBD pathway and not for the GdhA pathway (Fig. 1),
and governing the relative fluxes through these alternative
pathways is probably one of the most critical regulatory
problems faced by E. coli. We report direct regulation of
PgltB by Crp, in agreement with earlier indirect evidence
[15]. A microarray-based global analysis of E. coli genes
affected by Crp [33] did not identify the gltBDF operon,
but this probably reflects the rich culture medium (LB)
used in that work. Crp is broadly associated with the con-
trol of carbon and energy source utilization, usually acti-
vating genes for utilization of less-efficient carbon/energy
sources (relative to glucose) [33]. Competitions between
gdhA and gdhA+ strains [3,4] reveal a clear advantage for
the gdhA+ strain during glucose limitation, suggesting that
Crp modulates the relative activities of the two alternative
pathways for glutamate synthesis to favor the ATP-inde-
pendent pathway during growth on suboptimal carbon
sources [3,4]. The reciprocal effects of carbon source and
addition of cAMP on GdhA and GltBD activities are con-
sistent with just this role for Crp [15]. In addition, Crp-
Effect of Crp on protection of the gltBDF promoter by RNAPFigure 7
Effect of Crp on protection of the gltBDF promoter 
by RNAP. A fragment of gltBDF DNA from -571 to +51, 
labelled at the +51 end was used for DNase I protection 
assays. The first 4 lanes represent a sequencing ladder of the 
region. RNAP was used at 30 nM and Crp at 100 nM. Reac-
tions with CRP contained 2mM cAMP.
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synthetase gene (glnAp2) [34], so both enzymes for the
GlnA/GltBD pathway are controlled in parallel by Crp.
Our data show that Crp-cAMP binding in vitro (Fig. 5B, E)
is correlated with reduced transcription in vivo (Fig. 6),
and that RNAP generates a protection pattern at PgltB in
the presence of Crp-cAMP (Fig. 7, lane 7) different from
the pattern yielded by RNAP in the presence of IHF + Lrp
(Fig. 3B, lane 7). The Crp-cAMP repression thus appears to
alter RNAP binding rather than blocking it. The Crp foot-
print is centered at -65.5 relative to the start of gltB tran-
scription, close to the position from which Crp activates
class I promoters [35] where Crp binds between the C-ter-
minal domain of RpoA (αCTD) and region 4 of RpoD
(σ70). However optimal spacing from the proximal edge
of the Crp binding site to that of the -35 hexamer is 13–16
bp in class I promoters, while in PgltB this spacing is 21 bp
(Fig. 2A). Crp may thus repress PgltB by mispositioning or
trapping RNAP. Repression has been seen due to misposi-
tioning of RNAP via alternative binding sites [36], or trap-
ping at the promoter [37,38]. A recent global analysis
suggests that nearly a quarter of σ70 (RpoD)-dependent
promoters have bound RNAP that is "poised" but not
transcribing [39]. RNAP poised at PgltB would allow a
rapid increase of GltBD levels in the face of falling ammo-
nium concentrations, as the GdhA reaction becomes
increasingly inefficient (Fig. 1).
Role of ArgR in repressing gltBDF
As shown in Fig. 1, glutamate is a precursor of ornithine,
which in turn is converted to arginine. Thus regulation of
GltBD in response to arginine is an example of negative
feedback regulation. The relatively modest effects are
appropriate given the need for glutamate in many other
pathways. A similar feedback regulation of glutamate bio-
synthesis by ArgR was recently observed in Pseudomonas
aeruginosa [40]. The mechanism by which ArgR represses
PgltB is not clear, but our evidence is consistent with the
possibility that ArgR interferes with formation of the final
activation complex. As shown in Fig. 8, and illustrated in
Fig. 2, ArgR binds far upstream of the promoter, near the
Lrp-binding region. However ArgR does not appear to
have a major effect on Lrp binding (Fig. 9A). Our working
hypothesis is that ArgR allows pre-assembly of the Lrp-
IHF-RNAP complex, but blocks a specific contact required
for transcriptional activation. This would resemble the
suggested role of Crp (see above) in reducing gltBD
expression while allowing rapid return to full activation
should the appropriate conditions change.
Role of Lrp in regulation of gltBD
Lrp is not simply a signal of amino acid sufficiency. First,
gltBDF is one of the operons for which Lrp regulation is
relatively insensitive to the coregulator leucine [5,28]. Sec-
ond, Lrp levels (like those of the coactivator IHF [41]) are
sensitive to the alarmone ppGpp [42], which in turn is
affected by sufficiency of both amino acids and other
nutrients [43]. Lrp levels vary between media, and (like
those of the coactivator IHF [41]) also through the growth
cycle [42].
Much of what is known about regulation of GdhA, GlnA,
and GltBD is consistent with the expected reciprocal pat-
Table 1: Effects of arginine and ArgR on gltB::lacZ expression
Effect tested Strain/condition LacZ activity (units)1 Normalized data
LP1000 (rph) 11722 (1.00)
Addition of arginine3 LP1000 + Arg 660 0.56
LP1270 900 0.77
LP1270 + Arg 953 0.81
LP2020 (rph+) 736 0.63
LP2020 + Arg 402 0.34
Deletion of ArgR LP1050 (ΔargR) 2981 2.54
LP1050 + Arg 3035 2.59
LP2020 (rph+)4 648 0.55
LP2023 (rph+ ΔargR) 1283 1.09
1 One unit of LacZ (β-galactosidase) activity is defined as 1 nmol of ONPG hydrolyzed per min.
2 Samples were taken at several culture densities, and the resulting LacZ activity was plotted vs. culture density (as in Fig. 6). The activity was 
calculated from the slope of the line; in every case, the correlation coefficient of the least squares regression was ≥ 0.99.
3 Arginine hydrochloride was added to the medium to a final concentration of 7.5 mM.
4 These results were obtained on a different day from the other experiments.Page 10 of 17
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would expect GdhA levels to parallel those of [NH4+],
while GlnA and GltBD levels would perhaps follow the
inverse of [NH4+] and parallel those of ATP. In fact, gdhA
is repressed by Nac, with repression relieved in high
[NH4+], while neither glnA nor gltBD appear to respond
substantially to Nac [17,44,45]. Similarly, transcription of
both glnA and gltBD is repressed by Crp-cAMP while
effects on gdhA are unclear (this work, [34,46]). Con-
versely, both GlnA activity (indirectly, via glnL) and gltBD
transcription are boosted by Lrp, which has no obvious
effect on gdhA [5,6,28].
Modeling analysis [47] suggests that the major control of
relative flux between the alternative pathways shown in
Fig. 1 should involve regulation of GlnA activity (via ade-
nylylation and deadenylylation [48]). Lrp has major
effects on GlnA expression and adenylylation status in
response to ammonia levels [2,5,7]. The effect of Lrp on
GlnA expression and activity is indirect, probably involv-
ing the direct Lrp effect on GltBD expression that, in turn,
modulates the intracellular ratios of α-ketoglutarate,
glutamate, and glutamine [49]. This model requires
changes in gene expression levels for adaptation to sud-
den large changes in [NH4+], with gltBD needing to be
expressed above a threshold level. The 30-40-fold activa-
tion of PgltB by Lrp [28] is consistent with a major switch
above or below this critical threshold expression level. In
contrast, the effects of Crp and ArgR (and of leucine, in
this case) are smaller, fine-tuning controls that may mod-
ulate the flow of glutamine out of the middle of the GlnA-
GltBD pathway.
Conclusion
Results from this study demonstrate that the physiologi-
cally-important gltBDF operon of E. coli is subject to neg-
ative as well as positive control, and involves a third
member of the group of seven most-global transcriptional
regulatory proteins. In addition to the previously-demon-
strated direct positive roles of Lrp and IHF, there are direct
negative roles for Crp and ArgR. Lrp and IHF appear to sta-
bilize RNAP binding to the promoter, as no RNAP-
dependent footprint appears unless both Lrp and IHF are
present. Crp-cAMP can replace Lrp + IHF in potentiating
footprint formation by RNAP, though the resulting pro-
tection patterns are distinct. ArgR alters, but does not pre-
vent, footprint formation by RNAP + Lrp + IHF. It does
not appear that either repressor, Crp or ArgR, acts by inter-
fering with binding of the activators or of RNAP. This
study does not explore the specific mechanisms of activa-
tion or repression at gltBDF, but the results are consistent
with the possibility that Crp and ArgR inhibit transcrip-
tion in such a way as to leave the RNAP poised for rapid
transcription initiation when conditions require it. Given
the central importance of the regulation of glutamate bio-
synthesis, reflected by the involvement of Lrp and two
other E. coli global regulatory proteins, it would be
instructive to know whether this regulatory mechanism is
broadly conserved among related bacterial species
adapted to different nutritional environments.
Interactions between ArgR and the gltBDF promoter regionFigure 8
Interactions between ArgR and the gltBDF promoter 
region. A. The ArgR-binding sequences upstream of gltBDF 
(top two lines) compared to the symmetrical consensus 
ArgR-binding site [64]. Matches to the consensus are under-
lined. W = A or T, and N = A, C, G or T. B. Gel mobility 
shift analysis of ArgR binding to the region -406 to +246 of glt 
DNA. L-arginine was present in the reactions, the gel and 
running buffer (see Methods). C. DNase I protection assay of 
the region -462 to +161 bp upstream of gltBDF, labelled at 
the -462 end of the partner strand. The first 4 lanes repre-
sent a sequencing ladder of the partner strand in this region. 
ArgR concentrations of 0, 3.13, 6.25, 12.5, and 25 nM were 
used, and 5 mM L-arginine was present.
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Effect of ArgR on protection of the gltBDF promoter by RNAP and LrpFigure 9
Effect of ArgR on protection of the gltBDF promoter by RNAP and Lrp. The first 4 lanes represent the sequencing 
ladder of the region. A. A gltBDF DNA fragment from -462 to +161 labeled at the -462 end was used. The concentrations of 
both Lrp and ArgR were 25 nM. B. A fragment of gltBDF DNA from -571 to +51, labeled at the +51 end was used. The concen-
trations of proteins used were as follows: ArgR 25 nM, RNAP 50 nM, Lrp 25 nM and IHF 50 nM. Reactions contained 5 mM L-
arginine.
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Bacterial strains, plasmids and culture conditions
The strains, plasmids and PCR primers used in this study
are listed in Table 2. All strains were derivatives of E. coli
K-12 W3110 or LP2002 (in which the rph mutation of
W3110 was corrected; see below). For β-galactosidase
assays, strains were grown in glucose minimal MOPS
medium [50,51] containing ampicillin (20 μg/ml for
chromosomal and 80 μg/ml for plasmid-borne resist-
ance) or 7.5 mM L-arginine HCl (Sigma) where indicated.
Cultures grown to test the effects of Crp-binding site
mutations were grown in MOPS defined-rich medium
Table 2: E. coli strains1, plasmids, and primers used in this work
Strain/plasmid/primer Description Source or reference
Strains
BE3471 PS2209 gltB (psiQ39)::lacZ (Mu d1-1734) [28]
BE3479 PS2209 gltB (psiQ32)::lacZ (Mu d1-1734) [28]
BE3779 PS2209 gltB (psiQ32)::lacZ (Mu d1-1734) lrp-35::Tn10 [28]
BL21(DE3) F- ompT hsdSB (rB-mB-) gal dcm (DE3) Novagen
JWD3 BE1 (W3110 lrp-201::Tn10) pJWD2 [28]
LP1000 PS2209 gltB::lacZ transcriptional fusion at λatt with -406 to +246 of the gltBDF operon [14]
LP1050 LP1000 ΔargR This work
LP1060 BL21DE3/pLP1060 This work
LP1070 BL21DE3/pLP1070 This work
LP1080 BL21DE3/pLP1080 This work
LP1270 PS2209 gltB::lacZ transcriptional fusion at λatt with -270 to +246 of the gltBDF operon This work
LP2002 W3110 rph+ This work
LP2010 LP2002 ΔlacZYA This work
LP2020 LP2010 gltB::lacZ transcriptional fusion at λatt with -406 to +246 of the gltBDF operon This work
LP2023 LP2020 ΔargR This work
PM2003 PS2209/pPM2005 This work
PM2004 PS2209/pPM2006 This work
PS2209 W3110 Δlac-169 F. C. Neidhardt
W3110 F- prototroph rph F. C. Neidhardt
XL1-Blue recA1 endA1 gyrA96 thi-1 hsdR17 supE44 relA1 Δlac-pro [F' proAB lacIqZΔM15 Tn10] Stratagene
Plasmids
pBH403 pKK232-8 with promoterless lacZ gene inserted upstream of cat gene in a derivative of pBR322 [61, 62]
pPM2005 pBH403 with gltB promoter region cloned from BamHI to SalI This work
pPM2006 pPM2005 with mutations in the Crp-binding sequence This work
PJWD2 pTrc99A (Pharmacia) with the lrp coding sequence cloned into the NcoI site [28]
pLP1060 pET23b (Novagen) with the argR coding sequence cloned into the NdeI/XhoI sites This work
pLP1070 pET29a (Novagen) with the crp coding sequence inserted into the NdeI/XhoI sites This work
pLP1080 pET28A (Novagen) with the himA and himD coding sequences inserted in tandem into the NcoI//BamHI sites This work
pGEMT-easy Cloning vector Promega
pKO3 Suicide vector [54]
Primers
arg1 CGCCAGCAGCGCCGAGGACTGCGAC
arg2 CACTAATTATTGAGCTAATTAATACCGCGC
arg3 CATATGCGAAGCTCGGCTAAG
arg4 CTCGAGTTATTAAAGCTCCTGGTCGAACAGCTC
crp5 CCATATGGTGCTTGGCAAACCGC
crp6 CCTCGAGTTAACGAGTGCCGTAAACGAC
gltP1 CGGGATCCCATAATCACATAAATCACTTTTGCTTATC
gltP2 ACGCGTCGACAGCGGATTTCCAACTTATCG
gltcrp12 CAGTCAATTAATAAAGAATATAACGCTAAAGGCGGTTTCTGTACCAATAAGCTTGCC
gltcrp2 GGCAAGCTTATTGGTACAGAAACCGCCTTTAGCGTTATATTCTTTATTAATTGACTG
himA1 GGTACCGGCATCATTGAGGGATTGAACCTATGGCGCTTACA
himA2 CTCGAGCTCGTCTTTGGGCGAAGC
himD1 GGTACCTTAACCGTAAATATTGGCGCGATCGCG
himD2 TCATGACCAAGTCAGAATTGATAGAAGAC
lac6 GGATACGACGATACCGAAGACAGCTCATG
lac7 CGAGCCGGAAGCATAAAGTGTAAAGC
lac8 GCTTTACACTTTATGCTTCCGGCTCGGGCGTTCCTTGTCGGGTTATTCG
rph1 GCGTCTGATCGCCCGTGCTCTTCGCGC
rph23 CGTCGCTACAATGGATTCGATTCCCCCTCGGGC
rph33 GCCCGAGGGGGAATCGAATCCATTGTAGCGACG
rph4 ACGGCAGGTCCAGGTCGTGATGCTCCG
1All strains are Escherichia coli K-12.
2The underlined bases alter the Crp-binding site in the gltBDF promoter.
3The underlined italic base is inserted to replace the base deleted in the rph mutation.Page 13 of 17
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ml and 1 mM isopropyl-β-D-thiogalactoside (IPTG), in
the presence or absence of 10 μM dibutyryl-cAMP (Bio-
Mol Research Labs, Plymouth Meeting, PA). Plates for
most genetic work used agar containing "LB" medium
[52].
Construction of the rph+ strain LP2002 and its derivatives
The widely used E. coli K-12 strain W3110 contains a
frameshift mutation in rph associated with decreased lev-
els of the pyrE product orotate phosphoribosyltransferase
[29]. This frameshift was corrected as follows. A 790 bp
fragment of rph and downstream sequence was amplified
from W3110 chromosomal DNA using the polymerase
chain reaction (PCR) and the overlap extension procedure
[53]. The primers used were rph1-4 (Table 2). Primers
rph2 and rph3 contain the additional base pair required
to correct the frame shift in the rph gene (underlined italic
in Table 2). The PCR product was cloned into E. coli strain
XL-1Blue (Stratagene) using the pGEMT-easy vector
(Promega). The insert was then excised with NotI and
ligated into NotI-digested suicide vector pKO3 [54]. Elec-
trocompetent W3110 cells were transformed with pKO3
carrying the modified rph gene, and integrants were
selected at 43°C. Cells that had lost the plasmid were iso-
lated by plating on LB agar containing 5% sucrose, which
selects against the plasmid sacB gene [54]. Colonies from
LB-sucrose plates were replica plated onto unsupple-
mented LB and LB-chloramphenicol (20 μg/ml). Colonies
that grew on LB plates but not on LB-chloramphenicol
were screened for correction of the frame shift in the rph
gene by amplifying the rph region by PCR and sequencing
the product. The resulting rph+ strain was designated
LP2002.
The lac operon was deleted from strain LP2002 using the
overlap extension protocol [53] with primers lac6-9
(Table 2). The lac6 primer corresponds to nucleotides 814
to 842 within the coding region of lacI; the lac7 primer is
complementary to the 5' region of primer lac8; the 3' end
of lac8 bridges the deletion region (see below), and lac9
corresponds to nucleotides 1019 to 1044 of the coding
region of cynX gene downstream of the lacZYA operon.
The final amplified product has a deletion starting imme-
diately upstream of the -10 region of the lacZYA operon
and extending to the 3' end of the lacA gene, leaving the
last 19 codons of lacA intact. This product was introduced
into the chromosome of LP2002 using the suicide vector
pKO3 [54]. The ΔlacZYA recombinants were identified as
white colonies on LB-Xgal plates, and the deletion was
verified by amplifying the chromosomal lac region and
sequencing the fragment. The resultant strain was desig-
nated LP2010. The gltB-lacZ transcriptional fusion from
LP1000 [14,55] was introduced into LP2010 via P1 trans-
duction [55] and designated LP2020.
Construction of ΔargR strains
A portion of argR was deleted from strains LP1000 and
LP2020 as follows. The argR gene from strain PS2209
(W3110 Δlac-169 from F. C. Neidhardt) was amplified
from chromosomal DNA by PCR, using the primers arg1
and arg2 (Table 2). The amplified product was ligated into
the pGEMTeasy vector (Promega). The argR fragment was
excised from the vector with NotI, and the region of argR
coding for amino acids 15–90 were deleted in-frame by
removing a DraI/EcoRV fragment from the argR gene and
religating the blunt ends. This fragment was ligated into
suicide vector pKO3 [54] and introduced into strains
LP1000 and LP2020. Prospective mutants were screened
by amplifying the argR region from their genomic DNA;
the amplified fragment was shorter in the deletion
mutants. The ΔargR strains were designated LP1050
(LP1000 derivative) and LP2023 (LP2020 derivative).
CipherGen ProteinChip™ assays
Surface-enhanced laser desorption and ionization
(SELDI) ProteinChip technology (Ciphergen Biosystems,
currently distributed by BioRad, Hercules, CA) was used
to identify proteins binding to the upstream region of the
gltBDF operon. In this approach, biotin-labeled gltB DNA
(from -406 to +246) was attached to streptavidin-coated
chips and incubated with centrifugally-cleared whole-cell
extracts. The masses of proteins that bound to the DNA
fragments were determined using SELDI mass spectros-
copy. This binding experiment was carried out under non-
stringent conditions so as to detect relatively weak
binding interactions. E. coli cells (strain W3110) were
grown in glucose minimal MOPS medium and opened
using glass beads in a BeadBeater (BioSpec Products, Bar-
tlesville, OK). PS-1 (carbonyl diimidazole) ProteinChips
were coated with streptavidin (Pierce, Immunopure™) at
0.2 microgram/spot, washed, and the unbound sites were
blocked with 1 M ethanolamine (pH 8.0). The DNA, gen-
erated by PCR using biotinylated primers, was first bound
to the streptavidin on the chip, and then incubated with
cell extract in 20 mM Tris-acetate (pH 8.0), 0.1 mM EDTA,
0.1 mM dithiothreitol, 250 mM NaCl, 4 mM Mg acetate,
12.5% glycerol (v:v), and 200 μg/ml of salmon sperm
DNA (Amersham Pharmacia Biotech, N.J.). The chips
were washed with 20 mM Tris-acetate containing 0.1%
Triton X-100. The matrix EAM-1 (Ciphergen) was added
to the chip prior to SELDI mass analysis.
Expression and purification of Lrp, ArgR, Crp and IHF
In all cases, protein purity was assessed from single (or, in
the case of IHF, double) Coomassie-stained bands when
μg amounts were loaded onto SDS polyacrylamide gels.
Lrp was purified from strain JWD3 and isolated as previ-
ously described [28]. The genes argR, crp, himA and himD
(the latter two coding for IHF subunits) were amplified
from strain W3110 chromosomal DNA. The argR genePage 14 of 17
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cloned into the expression vector pET23b (Novagen) at
the NdeI/XhoI sites creating pLP1060, and introduced into
the expression host BL21(DE3) (Novagen) which carries
an inducible gene for T7 RNAP. The protein was purified
from the resulting strain LP1060, as described by Sunner-
hagen et al. [56].
The crp gene was amplified using primers crp5 and crp6
(Table 2), ligated into the NdeI/XhoI sites of expression
vector pET29a (Novagen) to create pLP1070, and intro-
duced into strain BL21(DE3) resulting in strain LP1070.
The overexpressed protein was purified using a nickel
affinity column (Pharmacia) since the wild type Crp
(without a his-tag) binds nickel columns with moderate
affinity [57].
The genes himA and himD were amplified from W3110
chromosomal DNA using primers himA1 and himA2 and
primers himD1 and himD2 (Table 2). The amplified
products were ligated in tandem into the expression vec-
tor pET28a (Novagen) at the NcoI/BamHI sites to create
pLP1080, and introduced into strain BL21(DE3). The
strain was designated LP1080. IHF with an N-terminal
histidine tag on HimA was purified using a 3 ml Hi-Trap
Heparin Sepharose column from Pharmacia [58].
Construction of PgltB-lacZ fusion and variant with altered 
Crp-binding site
The promoter region upstream of gltB was amplified from
E. coli chromosomal DNA using primers gltP1-2 (Table 2),
and the resulting PCR product was digested with BamHI
and SalI. This product was ligated into pBH403, a deriva-
tive of pKK232-8 with a promoterless lacZ gene between
two bidirectional transcription terminators, to generate
pPM2005 (Table 2). This process was repeated with a
mutagenic primer pair (gltcrp1-2, Table 2) to generate
pPM2006, which has alterations within the Crp-binding
site in the glt promoter. Plasmids were sequence con-
firmed and used to transform the ΔlacZ W3110 derivative
PS2209.
β-galactosidase assays
Cultures were grown to exponential phase in the indicated
media. Samples were taken at 30-min intervals through-
out the growth period. Levels of β-galactosidase were
determined by o-nitrophenyl-β-D-galactoside (ONPG)
hydrolysis as described by Platko et al. [59]. β-galactosi-
dase levels were plotted against culture absorbance, and
points were fitted via linear regression. The resulting slope
yields the β-galactosidase acitivity.
Mobility shift and DNase I protection assays
RNA polymerase holoenzyme was purchased from Epi-
centre Biotechnologies (Madison, WI). Assays were car-
ried out as described in Paul et al. [14] except where
indicated. In electrophoretic mobility shift experiments
involving ArgR, the reaction mixture and the polyacryla-
mide gel both contained 5 mM L-arginine, and the run-
ning buffer (1 × TBE [90 mM Tris borate, pH 8.3, 0.2 mM
EDTA]) contained 1 mM L-arginine. Crp-DNA binding
was carried out in a buffer modified from Seoh and Tai
[60] containing 10 mM Tris-HCl (pH 8.0), 50 mM KCl,
1.0 mM EDTA, 0.1 mM DTT, 50 μg/ml BSA, 10 μg/ml poly
(dI-dC):poly(dI-dC) from Pharmacia and 12.5% glycerol.
cAMP (20 mM, Sigma) was added to the reaction buffer,
the gel and the running buffer (0.5 × TBE). The buffer for
DNase I protection assays (10 mM Tris-HCl, pH 8.0, 5
mM MgCl2, 1 mM CaCl2, 2 mM dithiothreitol, 50 mg of
bovine serum albumin/ml and 2 μg of poly(dI-
dC):poly(dI-dC)/ml) contained 5 mM L-arginine or 20
mM cAMP for reactions involving ArgR and Crp respec-
tively.
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